1.21
iBio Inc stock is traded at $1.21, with a volume of 4.19M.
It is down -4.72% in the last 24 hours and up +46.35% over the past month.
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$1.27
Open:
$1.26
24h Volume:
4.19M
Relative Volume:
1.59
Market Cap:
$23.78M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.1825
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
+42.35%
1M Performance:
+46.35%
6M Performance:
+42.86%
1Y Performance:
-56.79%
iBio Inc Stock (IBIO) Company Profile
Name
iBio Inc
Sector
Industry
Phone
302-355-0650
Address
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IBIO
iBio Inc
|
1.21 | 25.72M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Oppenheimer | Outperform |
| Oct-17-25 | Initiated | Leerink Partners | Outperform |
| May-28-24 | Initiated | Chardan Capital Markets | Buy |
| Nov-29-21 | Initiated | JMP Securities | Mkt Outperform |
| Jan-22-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-26-20 | Initiated | Alliance Global Partners | Buy |
View All
iBio Inc Stock (IBIO) Latest News
Why iBio Inc. (0JV0) stock could be next leaderJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Risk vs reward if holding onto iBio Inc.2025 Biggest Moves & AI Powered Buy/Sell Recommendations - newser.com
Why iBio Inc. stock is rated strong buyMarket Movers & Weekly Consistent Profit Watchlists - newser.com
Analyzing iBio Inc. with multi timeframe chartsMarket Sentiment Report & Technical Pattern Alert System - newser.com
How buybacks impact iBio Inc. stock valueJuly 2025 Technicals & Stepwise Entry/Exit Trade Alerts - newser.com
Real time pattern detection on iBio Inc. stock2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com
iBio (IBIO) Gains Attention with Promising Obesity Treatment - GuruFocus
Biotech Alert: Searches spiking for these stocks today - TipRanks
Does iBio Inc. (0JV0) stock trade below intrinsic value2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - newser.com
iBio (IBIO) Gains Positive Outlook with Analyst Coverage and Inn - GuruFocus
Is IBIO Stock On The Verge Of A Breakthrough? - StocksToTrade
iBio Surges: Big Moves on the Horizon? - timothysykes.com
Is iBio Inc. stock attractive for long term wealth building2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - newser.com
iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - The Manila Times
iBio (NASDAQ: IBIO) fireside chat Nov 10 at 8:30 a.m. ET on obesity pipeline, Guggenheim - Stock Titan
Why Did iBio Shares Surge Over 11% In Pre-Market Trading? - Benzinga
IBIO insider Form 4: CFO awarded 75,000 options, vesting over 3 years - Stock Titan
Form 4: iBio awards 55,000 options to Chief Legal Officer - Stock Titan
What analysts say about iBio Inc 0JV0 stockGrowth vs. Value Investing & Exceptional Return Investment - earlytimes.in
iBio (IBIO) Gains Attention with Innovative Drug Development - GuruFocus
Ibio Inc. sell Wolf_of_WS - sharewise.com
iBio initiated with an Outperform at Oppenheimer - MSN
Key resistance and support levels for iBio Inc.July 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
iBio Inc. stock retracement – recovery analysisMarket Risk Summary & Safe Capital Growth Trade Ideas - newser.com
IBIO Stocks Skyrocket: An In-Depth Overview - StocksToTrade
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - Benzinga
This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Oppenheimer Initiates Coverage of iBio (IBIO) with Outperform Recommendation - Nasdaq
iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs - ts2.tech
Oppenheimer Initiates Coverage on iBio With Outperform Rating, $5 Price Target - MarketScreener
iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025 - Stock Titan
Oppenheimer Initiates Coverage on IBIO with an Outperform Rating - GuruFocus
Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Is iBio Inc. (0JV0) stock worth holding before Fed meetingGap Down & Weekly Watchlist for Hot Stocks - newser.com
Oppenheimer initiates iBio stock with Outperform rating on obesity drug potential - Investing.com Canada
What analysts say about iBio Inc stockMarket Insider Reports & Grow Steadily With Our Wealth Roadmap - earlytimes.in
How to manage a losing position in iBio Inc.Index Update & Safe Swing Trade Setup Alerts - newser.com
Tick level data insight on iBio Inc. volatility2025 Institutional Moves & Detailed Earnings Play Strategies - newser.com
Form 4: iBio awards CEO 180,000 options; first vest 10/20/2026 - Stock Titan
Real time alert setup for iBio Inc. performanceWeekly Trend Summary & Risk Managed Investment Strategies - newser.com
iBio initiated with an Outperform at Leerink - MSN
iBio Inc Stock (IBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):